Sandoz has successfully completed the acquisition of worldwide brand rights for antifungal agent Mycamine - Market News

MARKET NEWS (Aug 28, 2023) — Sandoz, a global leader in generic and biosimilar medicines, has successfully completed the acquisition of worldwide brand rights for leading systemic antifungal agent Mycamine (micafungin sodium, Funguard in Japan) from Astellas. Through this acquisition of the leading global echinocandin, one of three major antifungal classes, Sandoz significantly reinforces its global hospital offering and leading anti-infectives portfolio... novartis.com